Catalyst Pharmaceuticals Inc (CPRX)

Financial leverage ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total assets	US$ in thousands	470,114	413,211	443,896	407,227	375,630	333,114	267,309	246,972	237,788	223,248	209,130	197,216	192,354	174,860	131,412	117,880	112,376	96,691	78,234	61,077
Total stockholders’ equity	US$ in thousands	387,881	348,548	375,294	333,661	300,421	270,041	241,092	220,221	206,831	198,661	188,944	178,651	169,598	156,628	111,201	99,676	87,630	77,983	63,282	51,176
Financial leverage ratio		1.21	1.19	1.18	1.22	1.25	1.23	1.11	1.12	1.15	1.12	1.11	1.10	1.13	1.12	1.18	1.18	1.28	1.24	1.24	1.19

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $470,114K ÷ $387,881K
= 1.21

The financial leverage ratio of Catalyst Pharmaceuticals Inc has been fluctuating over the past few quarters. The ratio indicates the company's level of debt relative to its equity, with higher values suggesting higher financial leverage or dependency on debt financing.

Based on the data provided, the financial leverage ratio ranged from 1.10 to 1.28 over the last five quarters. The ratio peaked at 1.28 in the fourth quarter of 2019, indicating a higher level of debt compared to equity at that time. However, in the subsequent quarters, the ratio generally decreased, reaching a low of 1.10 in the second quarter of 2021.

Overall, Catalyst Pharmaceuticals Inc has maintained a moderate level of financial leverage, with fluctuations possibly driven by changes in debt levels or equity contributions. Investors and stakeholders may monitor this ratio to assess the company's ability to meet its financial obligations and the overall risk associated with its capital structure.